Study of macupatide for weight loss in people with overweight or obesity
Treatments studied
Part of Hormones & metabolism clinical trials.
This study tests an investigational drug called macupatide to see if it can help people with overweight or obesity lose weight. It is for people who do not have type 2 diabetes and are in generally good health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older and live in Japan.
- Your body mass index (BMI) must be 25 or higher.
- Your weight must have been stable for the past 3 months (less than 5% change).
- You must not have diabetes or a history of chronic heart, liver, or kidney disease.
- You must not have had any cancer in the past 5 years, except for certain skin cancers that were removed.
- You must not have had weight-loss surgery or used prescription weight-loss drugs in the past 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests two new injectable drugs (macupatide and eloralintide) alone or together to help adults with obesity or excess weight lose weight. The goal is to see if these medications are safe and effective for weight management.
This trial tests an experimental drug (Eloralintide) to see if it can help with weight management. It is for people who have a body mass index (BMI) between 25 and 45 and stable weight.
This study tests a new medicine called PF-08653945 to see how it enters the blood in adults who are overweight or have obesity. The results will help doctors understand how the medicine works in the body.
This study tests an experimental medicine (eloralintide) to see if it can help people with overweight or obesity lose weight without having diabetes. The medicine works by affecting hormones that help control appetite and body weight.
This trial tests if an investigational drug called eloralintide can help people with obesity or overweight lose weight. It is for people who do not have type 2 diabetes and who have tried but struggled to lose weight on their own.
This study tests an investigational medication called eloralintide to see if it helps with weight loss in women who are overweight or have obesity. Participants will receive the study drug and be monitored for safety and effectiveness.
Hear when a new Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.